Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ibn Alhaytham HospitalAMM:IBNH 33 EV-to-EBIT is 25.28 as of Jul. 18, 2026, which is 94% above its 10-year median of 13.00. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.84 (Fairly Valued). The stock has 9 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Ibn Alhaytham Hospital ranks worse than 70% on this metric.
The historical rank and industry rank for Ibn Alhaytham Hospital's EV-to-EBIT or its related term are showing as below:
AMM:IBNH'
s EV-to-EBIT Range Over the Past 10 Years
Min: -114.85 Med: 13 Max: 731.74
Current: 25.28
During the past 13 years, the highest EV-to-EBIT of Ibn Alhaytham Hospital was 731.74. The lowest was -114.85. And the median was 13.00.
AMM:IBNH's EV-to-EBIT is ranked worse than 70% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 15.72
vs AMM:IBNH: 25.28
Ibn Alhaytham Hospital (AMM:IBNH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ibn Alhaytham Hospital's Enterprise Value for the quarter that ended in Mar. 2026 was JOD25.96 Mil.
Ibn Alhaytham Hospital's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD1.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibn Alhaytham Hospital EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ibn Alhaytham Hospital's EV-to-EBIT falls into.
Ibn Alhaytham Hospital's current Enterprise Value is JOD27.96 Mil.
Ibn Alhaytham Hospital's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD1.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibn Alhaytham Hospital (AMM:IBNH) has a EV-to-EBIT of 25.28 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ibn Alhaytham Hospital and its competitors. This is 94% above median its historical median of 13.00. According to the industry distribution chart, Ibn Alhaytham Hospital ranks #329 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 70%.
Is Ibn Alhaytham Hospital's EV-to-EBIT too high?
Ibn Alhaytham Hospital's current EV-to-EBIT of 25.28 is 94% above median its 10-year median of 13.00. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. Ibn Alhaytham Hospital's value of 25.28 is 60.8% above this industry median. Based on the distribution chart, Ibn Alhaytham Hospital ranks #329 out of 470 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ibn Alhaytham Hospital ranks #329 out of 470 companies for EV-to-EBIT. This places Ibn Alhaytham Hospital in the lower half of its industry. The industry median EV-to-EBIT is 15.72. Ibn Alhaytham Hospital's value of 25.28 is 60.8% above this benchmark. While the company's 10-year median is 13.00 vs. the industry median of 15.72, Ibn Alhaytham Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibn Alhaytham Hospital's current EV-to-EBIT of 25.28 is 60.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ibn Alhaytham Hospital and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibn Alhaytham Hospital's current EV-to-EBIT is 25.28, which is 94% above median its own 10-year median of 13.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital (AMM:IBNH) is currently considered Fairly Valued. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current EV-to-EBIT is 25.28, which is 94% above median its 10-year median of 13.00 and 60.8% above the Healthcare Providers & Services industry median of 15.72. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current EV-to-EBIT is 25.28 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued.
The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84.
GuruFocus considers Ibn Alhaytham Hospital to be Fairly Valued.
Key valuation signals for AMM:IBNH:
EV-to-EBIT: 25.28 (94% above median its 10-year median of 13.00)
GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
Industry Position: 60.8% above the Healthcare Providers & Services median (#329 of 470)
No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score
Get the complete analysis for AMM:IBNH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:IBNH has been successfully added to your 
